J. Lawrence Merritt, II, MD, is attending physician at Seattle Childrens Hospital and assistant professor in the Department of Pediatrics at the University of Washington School of Medicine. He joined Childrens after completing his pediatric residency, medical genetics residency and biochemical genetics fellowship at the Mayo Clinic in Rochester, MN.
He provides inpatient and outpatient clinical services in biochemical genetics at Childrens and in the Spokane travel clinics. His clinical interests include long-term follow up of infants with abnormal newborn screens, urea cycle disorders and fatty acid oxidation disorders. He is the site principle investigator for the Urea Cycle Disorders Consortium Longitudinal study and received a grant to study the effects of newborn screening in patients and families with urea cycle disorders. He is involved with development of novel pharmaceutical therapies for treatment of urea cycle disorders. He is also an investigator in the Western State Genetic Services Collaborative study of the long-term outcomes from infants with positive newborn screens for Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.